JPM vs NMFC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
NMFC exhibits significant financial instability characterized by a mediocre Piotroski F-Score of 4/9 and a technical trend of 0/100. While the stock trades at a discount to book value (P/B 0.71), it is priced well above its Graham Number ($6.44) and intrinsic value ($1.12). The most alarming metric is the 800% dividend payout ratio, which suggests the current 15.57% yield is unsustainable based on GAAP earnings. Negative revenue growth and a consistent track record of earnings misses further degrade the outlook.
Compare Another Pair
Related Comparisons
JPM vs NMFC: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and New Mountain Finance Corporation (NMFC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.